Papers
4
Total Citations
39
H-Index
3
About
Dr. Luisa Egen is a pioneering urologic surgeon whose research centers on robotic-assisted and laser-based surgical techniques for prostate and kidney conditions. Her most impactful work, a 2023 systematic review and meta-analysis of randomized controlled trials comparing robot-assisted to conventional laparoscopic radical prostatectomy, has already garnered 26 citations, establishing her as a leading voice in evidence-based surgical oncology. Dr. Egen’s major contributions include rigorous comparative effectiveness studies, such as her propensity score-matched analysis of Thulium laser enucleation of the prostate (ThuLEP) versus robot-assisted simple prostatectomy (RASP) for large-gland benign prostatic hyperplasia, demonstrating her commitment to optimizing perioperative outcomes. She is also the lead author of the ROBOCOP II trial protocol, a landmark randomized controlled feasibility study comparing robotic-assisted and open partial nephrectomy for renal neoplasms—a critical step toward filling a longstanding evidence gap. Her recent work extends to comparing Holmium laser enucleation (HoLEP) with RASP, further solidifying her expertise in minimally invasive prostate surgery. With publications spanning English and German-language journals, Dr. Egen’s research directly informs clinical decision-making, offering surgeons and patients clearer guidance on safety, efficiency, and recovery. Her growing citation record and leadership in trial design mark her as an emerging authority in urologic robotics and laser surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4